Worley Matthew J, Witkiewitz Katie, Brown Sandra A, Kivlahan Daniel R, Longabaugh Richard
Department of Family Medicine, University of California, Los Angeles, Los Angeles, California.
Alcohol Clin Exp Res. 2015 Jan;39(1):93-100. doi: 10.1111/acer.12605.
Oral naltrexone is an efficacious medication for treatment of alcohol dependence, but small effect sizes and variability in outcomes suggest the presence of person-level moderators of naltrexone response. Identification of contextual or psychosocial moderators may assist in guiding clinical recommendations. Given the established importance of social networks in drinking outcomes, as well as the potential effects of naltrexone in reducing cue reactivity which may be especially important among those with more heavy drinkers and more alcohol cues in their networks, we examined pretreatment social network variables as potential moderators of naltrexone treatment effects in the COMBINE study.
The sample included all COMBINE study participants in medication conditions with full data on the Important People Inventory (IPI) and covariates at intake (N = 1,197). The intake IPI assessed whether participants had any frequent drinkers in their network and the average frequency of contact with these drinkers. The effects of treatment condition, pretreatment network variables, and their interactions on percent heavy drinking days were tested in hierarchical linear models, controlling for demographics and baseline clinical covariates.
In treatment conditions involving medical management and combined behavioral intervention (CBI), the effects of active naltrexone on heavy drinking were significantly greater for individuals with frequent drinkers in their network (z = -2.66, p < 0.01) and greater frequency of contact with those drinkers (z = -3.19, p < 0.01). These network variables did not moderate the effects of active naltrexone without CBI.
When delivered in conjunction with behavioral interventions, naltrexone can be more potent for alcohol-dependent adults who have greater contact with frequent drinkers prior to treatment, which may indicate patterns of environmental exposure to alcohol. Contextual, social risk factors are a potential avenue to guide personalized treatment of alcohol dependence.
口服纳曲酮是治疗酒精依赖的一种有效药物,但效应量较小且结果存在变异性,这表明存在影响纳曲酮反应的个体水平调节因素。识别情境或心理社会调节因素可能有助于指导临床建议。鉴于社交网络在饮酒结果中已确立的重要性,以及纳曲酮在降低线索反应性方面的潜在作用,这在饮酒量更大且社交网络中酒精线索更多的人群中可能尤为重要,我们在综合治疗酒精依赖研究(COMBINE研究)中,将治疗前社交网络变量作为纳曲酮治疗效果的潜在调节因素进行了研究。
样本包括所有参与药物治疗组的COMBINE研究参与者,他们在入组时拥有关于重要人物清单(IPI)和协变量的完整数据(N = 1197)。入组时的IPI评估了参与者的社交网络中是否有任何频繁饮酒者以及与这些饮酒者的平均接触频率。在分层线性模型中测试了治疗条件、治疗前网络变量及其交互作用对重度饮酒天数百分比的影响,同时控制人口统计学和基线临床协变量。
在涉及药物管理和联合行为干预(CBI)的治疗条件下,社交网络中有频繁饮酒者的个体,活性纳曲酮对重度饮酒的影响显著更大(z = -2.66,p < 0.01),并且与这些饮酒者的接触频率更高时影响也更大(z = -3.19,p < 0.01)。在没有CBI的情况下,这些网络变量并未调节活性纳曲酮的效果。
当与行为干预联合使用时,纳曲酮对治疗前与频繁饮酒者有更多接触的酒精依赖成年人可能更有效,这可能表明存在接触酒精的环境模式。情境性社会风险因素是指导酒精依赖个性化治疗的一个潜在途径。